In a recent article from Forbes, the worst performing biotech stocks from 2013 were listed. Of the companies that posted negative results, the worst damage came to those that presented bad clinical data or had run-ins with the U.S. Food and Drug Administration. The Worst-Performing Biotech Stocks of 2013 CLSN Celsion Corporation 52.9 -89.4 ASTM […]